Cite
Gracia-Maldonado G, Clark J, Burwinkel M, et al. LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for Mixed Lineage Leukemia-Rearranged acute leukemia. Haematologica. 2021;doi: 10.3324/haematol.2020.257451.
Gracia-Maldonado, G., Clark, J., Burwinkel, M., Greenslade, B., Wunderlich, M., Salomonis, N., Leone, D., Gatti, E., Pierre, P., Kumar, A. R., & Lee, L. H. (2021). LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for Mixed Lineage Leukemia-Rearranged acute leukemia. Haematologica, . https://doi.org/10.3324/haematol.2020.257451
Gracia-Maldonado, Gabriel, et al. "LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for Mixed Lineage Leukemia-Rearranged acute leukemia." Haematologica vol. (2021). doi: https://doi.org/10.3324/haematol.2020.257451
Gracia-Maldonado G, Clark J, Burwinkel M, Greenslade B, Wunderlich M, Salomonis N, Leone D, Gatti E, Pierre P, Kumar AR, Lee LH. LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for Mixed Lineage Leukemia-Rearranged acute leukemia. Haematologica. 2021 Apr 29; doi: 10.3324/haematol.2020.257451. Epub 2021 Apr 29. PMID: 33910331.
Copy
Download .nbib